Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EL1491 / 1||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Body temperature, Death, Pyrexia, Fibromyalgia
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: RIVOTRIL; PIOGLITAZON; CONTROLOC [PANTOPRAZOLE SODIUM SESQUIHYDRATE]; ALOPURINOL; ATORIS; AMLOPIN [AMLODIPINE BESILATE]; SORTIS; AMYZOL [AMITRIPTYLINE HYDROCHLORIDE]
Preexisting Conditions: Medical History/Concurrent Conditions: Anaemia; Cerebrovascular infarction (St. post CVI); Diabetes mellitus; Penicillin allergy; Recurrent urinary tract infection; Tetraplegia
Diagnostic Lab Data: Test Date: 202101; Test Name: Body temperature; Result Unstructured Data: Test Result:38.0-38.3 Centigrade
CDC 'Split Type': HRPFIZER INC2021190007
Write-up: Death; Fibromyalgia; Fever 38.0 ? C - 38.3 ? C for three days; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB. This is a report received from the regulatory authority. The regulatory authority report number is HR-HALMED-300043964. A 57-year-old male patient received the first dose of the bnt162b2 (COMIRNATY; Lot Number: EL1491), intramuscularly on 07Jan2021 at 0.3 mL, single for COVID-19 immunization. Medical history included recurrent urinary tract infection from an unknown date and unknown if ongoing, penicillin allergy from an unknown date and unknown if ongoing, diabetes mellitus from an unknown date and unknown if ongoing, tetraplegia from an unknown date and unknown if ongoing, cerebrovascular infarction from an unknown date and unknown if ongoing (status post CVI), anaemia from an unknown date and unknown if ongoing. Concomitant medications included clonazepam (RIVOTRIL), pioglitazone hydrochloride (MANUFACTURER UNKNOWN), pantoprazole sodium sesquihydrate (CONTROLOC [PANTOPRAZOLE SODIUM SESQUIHYDRATE]), alopurinol (MANUFACTURER UNKNOWN), atorvastatin calcium (ATORIS) , amlodipine besilate (MANUFACTURER UNKNOWN), atorvastatin calcium (SORTIS), amitriptyline hydrochloride (AMYZOL [AMITRIPTYLINE HYDROCHLORIDE]); all taken for an unspecified indication from an unspecified date to an unspecified date. On 08Jan2021, the patient experienced: fibromyalgia, and fever 38.0 ? C - 38.3 ? C for three days; both of which caused death. On 19Jan2021, the patient experienced: death (death, medically significant). The patient underwent lab tests and procedures which included body temperature: 38.0-38.3 Centigrade in Jan2021. The clinical outcome of the events was fatal. The patient died on 19Jan2021, in a hospital, due to unknown cause of death (as reported), fibromyalgia and fever. It was unknown if an autopsy was performed. Sender comments: 18Feb2021: Despite several contact attempts with the reporter, additional medicinal documentation has not been received. Based on the currently available information, it is not possible to assess causal relationship between fatal outcome and vaccine administration. No follow-up attempts are possible. No further information is expected. ; Reported Cause(s) of Death: Fibromyalgia; Fever; Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166